Longeveron (NASDAQ: LGVN) Stock Soars on FDA Milestone for Lomecel-B™ in Alzheimer’s Treatment
Longeveron stock (NASDAQ: LGVN) surged during intraday trading Wednesday after the company achieved the FDA milestone with RMAT designation for […]
LGVN
Longeveron (NASDAQ: LGVN) Stock Doubles on Promising ELPIS II Trial Update
Longeveron (NASDAQ: LGVN) stock more than doubled during intraday trading Wednesday after the company revealed updates from the ELPIS II
Longeveron (NASDAQ: LGVN) Stock Doubles on Promising ELPIS II Trial Update Read More »